glp-1 news today nov 2025 New oral drug delivers up to 12% weight loss in 36 weeks GLP-1 drugs can be ‘too

This surge coincided with Zepbounds approval for OSA, marking the largest observed difference in uptake between patients with and without a comorbidity

Together, these clinically studied ingredients work to support strength, power, lean muscle development, endurance, workout capacity, and recovery while helping reduce muscle breakdown and fatigue

Tirzepatide is a promising drug withdual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor activation that has revolutionized the treatment of type 2 diabetesmellitus (T2DM) as an adjunct to ...

Overall, the GLP-1 market is expected to experience annual growth exceeding 20% and will hit $133 billion worldwide by 2030, according to a MarketWatch report from February.

Can GLP-1 agonists improve ovarian cancer outcomes

We share the protocol that we believe can help the plastic surgery team standardize safety strategies to be considered prior to elective surgery in patients who are treated with GLP-1 RA